Liv Hospital offers accurate COVID-19 testing and expert evaluation for international patients, ensuring timely diagnosis and personalized care.
Liv Hospital offers accurate COVID-19 testing and expert evaluation for international patients, ensuring timely diagnosis and personalized care.
Send us all your questions or requests, and our expert team will assist you.
COVID-19 Diagnosis and Evaluation
Effective diagnosis and evaluation of COVID-19 is essential for timely treatment, containment, and optimal outcomes, especially for international patients navigating a new health system. According to the World Health Organization, over 600 million confirmed cases have been recorded worldwide, underscoring the need for precise and coordinated medical assessment. This page provides a comprehensive overview of the diagnostic tools, clinical assessment methods, imaging options, laboratory markers, and follow‑up strategies employed at Liv Hospital. Whether you are a traveler seeking care, a referring physician, or a patient planning a medical visit, the information below will help you understand the full spectrum of services available for COVID‑19 diagnosis and evaluation.
Testing Modalities for COVID-19
Accurate testing forms the backbone of COVID-19 diagnosis and evaluation. Liv Hospital offers a tiered approach that matches the clinical scenario, ranging from highly sensitive molecular assays to rapid antigen tests for point‑of‑care screening.
Reverse transcription polymerase chain reaction (RT‑PCR) remains the gold standard. Nasopharyngeal swabs are processed in our accredited laboratory, delivering results within 4‑6 hours for urgent cases. The test detects viral RNA with a sensitivity exceeding 95% when performed correctly.
For patients requiring immediate decisions—such as travelers or emergency admissions—antigen tests provide results in 15‑30 minutes. While slightly less sensitive (≈80% in symptomatic individuals), they are valuable for large‑scale screening and outbreak control.
Serological assays identify past infection by detecting IgM and IgG antibodies. These tests are useful for epidemiological studies and assessing immune response, but they do not replace PCR for acute diagnosis.
Test Type | Turnaround Time | Sensitivity | Typical Use
|
|---|---|---|---|
RT‑PCR | 4‑6 hours | ≥95 % | Confirmatory diagnosis |
Rapid Antigen | 15‑30 minutes | ≈80 % | Screening, urgent triage |
Serology | 1‑2 days | Variable (IgG ≈90 %) | Post‑infection assessment |
Choosing the appropriate test is a collaborative decision between the patient, interpreter, and our infectious disease specialists, ensuring that every international traveler receives care aligned with their health status and travel timeline.
Clinical Assessment and Symptom Evaluation
Beyond laboratory testing, a thorough clinical assessment is vital for a complete diagnosis and evaluation of COVID-19. Our multidisciplinary team conducts a structured interview and physical examination that captures the full spectrum of disease presentation.
Key vital parameters are recorded at intake:
Abnormal findings—particularly a SpO₂ below 94%—prompt immediate escalation to advanced imaging and laboratory workup. For international patients, our multilingual staff ensures that symptom descriptions are accurately captured, reducing the risk of miscommunication.
Imaging Techniques in Diagnosis
Imaging complements laboratory data, especially when patients present with moderate to severe respiratory symptoms. Liv Hospital employs a range of modalities to visualize pulmonary involvement and guide therapeutic decisions.
Portable chest radiography is the first‑line imaging tool for bedside assessment. It can reveal bilateral infiltrates, consolidations, or atypical patterns suggestive of COVID‑19 pneumonia.
When X‑ray findings are equivocal, a high‑resolution computed tomography (CT) scan provides detailed visualization of ground‑glass opacities, crazy‑paving patterns, and disease distribution. CT has a reported sensitivity of >90% for detecting early COVID‑19 lung changes.
Point‑of‑care ultrasound (POCUS) offers a radiation‑free alternative, useful in intensive care settings. It detects B‑lines, pleural thickening, and consolidations with real‑time feedback.
Imaging Modality | Typical Findings | Advantages | Limitations
|
|---|---|---|---|
Chest X‑Ray | Bilateral infiltrates | Quick, bedside | Lower sensitivity early |
CT Scan | Ground‑glass opacities | High sensitivity | Radiation exposure |
Lung Ultrasound | B‑lines, pleural irregularities | No radiation, portable | Operator dependent |
Our radiology department coordinates seamlessly with infectious disease physicians to ensure that imaging results are interpreted within the broader context of each patient’s clinical picture.
Laboratory Markers and Risk Stratification
Beyond detecting the virus, laboratory tests help stratify disease severity and predict complications—a crucial component of comprehensive diagnosis and evaluation. Liv Hospital’s laboratory offers a full panel of inflammatory and coagulation markers.
COVID‑19 is associated with thrombotic events. We routinely assess prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels to guide anticoagulation therapy.
Elevated D‑dimer and troponin, for example, have been linked to higher mortality. Our clinicians use these data points to categorize patients into mild, moderate, or severe risk groups, which then determines the level of monitoring and therapeutic intensity.
Follow‑Up Evaluation and Long COVID Considerations
Recovery from acute infection does not always signify the end of the diagnostic journey. Ongoing evaluation is essential to identify and manage post‑acute sequelae, commonly referred to as “Long COVID.”
Our multidisciplinary rehabilitation team offers physiotherapy, occupational therapy, and neuro‑cognitive support tailored to each patient’s lingering symptoms.
Common long‑term issues include fatigue, chest pain, brain fog, and dysautonomia. Laboratory reassessment (e.g., CRP, thyroid function) and imaging are repeated when clinically indicated.
International patients benefit from coordinated care plans that include remote monitoring tools, ensuring continuity of care even after they return to their home countries.
Telemedicine and Remote Monitoring for International Patients
In the era of global travel, Liv Hospital extends its diagnosis and evaluation capabilities beyond the physical campus through secure telemedicine platforms.
For patients who have left Istanbul but require ongoing monitoring, we provide FDA‑approved rapid antigen kits and pulse oximeters that sync with our patient portal.
This digital infrastructure ensures that the quality of diagnosis and evaluation remains consistent, regardless of geographic location.
Why Choose Liv Hospital
Liv Hospital is a JCI‑accredited, internationally focused medical centre in Istanbul. Our dedicated International Patient Services team manages appointments, airport transfers, interpreter support, and accommodation, allowing patients to concentrate on their health. With state‑of‑the‑art laboratories, imaging suites, and a multidisciplinary team experienced in COVID‑19 care, we deliver precise diagnosis and comprehensive evaluation tailored to the needs of travelers and expatriates.
Ready to schedule your COVID‑19 assessment or need more information about our diagnostic services? Contact Liv Hospital’s International Patient Office today and let our experts guide you through a seamless, world‑class experience.
Send us all your questions or requests, and our expert team will assist you.
The hospital uses a tiered testing strategy. RT‑PCR, the gold‑standard molecular assay, detects viral RNA with >95% sensitivity and returns results in 4‑6 hours for urgent cases. Rapid antigen tests deliver results within 15‑30 minutes, useful for travelers and emergency admissions, though sensitivity is around 80% in symptomatic patients. Serology tests identify IgM and IgG antibodies to assess past infection and immune response, but they do not replace PCR for acute diagnosis. Test selection is made collaboratively with the patient, interpreter, and infectious disease specialists to match clinical needs and travel timelines.
After the initial test, clinicians conduct a structured interview and physical exam, recording vital signs such as temperature, heart rate, respiratory rate, blood pressure, and SpO₂. Abnormal SpO₂ (<94%) triggers advanced imaging and lab workup. Imaging (chest X‑ray, CT, lung ultrasound) visualizes lung involvement, while laboratory panels measure inflammatory markers (CRP, ferritin, IL‑6, D‑dimer) and organ function (renal, hepatic, cardiac). Elevated D‑dimer or troponin, for example, places patients in higher‑risk categories, guiding monitoring intensity and therapeutic decisions.
The first‑line tool is a portable chest X‑ray, which can quickly reveal bilateral infiltrates at the bedside. If X‑ray findings are inconclusive, a high‑resolution CT scan is performed, offering >90% sensitivity for early ground‑glass opacities and detailed disease distribution. For intensive care settings, point‑of‑care lung ultrasound provides a radiation‑free alternative, detecting B‑lines, pleural thickening, and consolidations in real time. Radiologists work closely with infectious disease physicians to interpret these images within the overall clinical context.
After acute illness, patients enter a post‑acute care pathway with virtual visits at 2‑week, 1‑month, and 3‑month intervals. Pulmonary function tests (spirometry, diffusion capacity) and cardiopulmonary exercise testing assess lingering respiratory limitations. A rehabilitation team delivers physiotherapy, occupational therapy, and neuro‑cognitive support tailored to each symptom profile. Persistent issues such as fatigue, chest pain, brain fog, or dysautonomia are monitored with repeat labs (e.g., CRP, thyroid) and imaging when indicated. International patients benefit from remote monitoring tools that sync with the hospital’s portal, ensuring continuity of care after they return home.
The hospital’s telemedicine platform supports multilingual video calls where clinicians discuss test results, prescribe medications, and arrange referrals. Patients receive FDA‑approved rapid antigen kits and pulse oximeters that automatically upload readings to the portal. Automated alerts flag abnormal SpO₂ or fever, prompting timely clinician review. If needed, the hospital coordinates handoffs to local healthcare providers, ensuring that the quality of diagnosis and evaluation remains consistent regardless of geographic location.
The accredited laboratory processes nasopharyngeal swabs for RT‑PCR with a high‑throughput workflow, delivering confirmatory results within 4‑6 hours for urgent cases. Rapid antigen tests, performed at point‑of‑care, provide a quick answer in 15‑30 minutes, making them ideal for travelers needing immediate clearance or for emergency department triage. Both testing pathways are integrated with the hospital’s electronic health record, allowing clinicians to view results instantly and make prompt management decisions.
Beyond confirming infection, the lab panel measures CRP, ferritin, IL‑6, and D‑dimer to gauge systemic inflammation and coagulopathy. Elevated D‑dimer and IL‑6 are associated with higher risk of thrombotic events and severe disease, while high troponin indicates cardiac involvement. Renal and liver function tests assess organ impact. Clinicians combine these values with clinical findings to assign patients to risk categories, which dictate monitoring frequency, need for anticoagulation, and potential escalation to intensive care.
Your Comparison List (you must select at least 2 packages)
